Cystic Fibrosis Related Diabetes Meeting
Advancements in the management of patients with Cystic Fibrosis have substantially extended their life expectancy. As CF patients age, there is an increased incidence of diabetes mellitus. This form of diabetes has features of both type 1 and type 2 diabetes and is called Cystic Fibrosis Related Diabetes or CFRD. CFRD occurs in 35% of young adults ages 20 to 29 and 43% of adults over 30 years of age. In addition, many CF patients with CFRD experience weight loss and have a steeper decline in lung function. In contrast to other types of diabetes, CFRD presents unique diagnostic and therapeutic challenges that necessitate more rigorous answers. The goal of this workshop is to better understand the causes and consequences of CFRD as well as discuss emerging strategies to better control this metabolic complication. During the two panel discussions, participants will identify gaps and develop research questions that need to be addressed to more fully understand the causes, consequences, and management of CFRD.
Lister Hill Auditorium
National Institutes of Health
Bethesda, MD 20892
Saul Malozowski, M.D., Ph.D.
Catherine McKeon, Ph.D.
Denise Hoffman, CMP
The Scientific Consulting Group, Inc.